{
  "retracted": false,
  "timestamp": 1589932800000,
  "updates": [
    {
      "timestamp": 1589960481345,
      "identifier": {
        "doi": "10.1186/s13058-020-01294-7"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s13058-019-1243-8"
  },
  "journal": "Breast Cancer Research",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer"
}
